Potassium Acetate Injection Shortage
Last Updated: April 10, 2024
Status: Current
Products Affected - Description
-
- Potassium acetate injection, Pfizer, 2 mEq/mL, 20 mL vial, 25 count, NDC 00409-8183-01
- Potassium acetate injection, Pfizer, 2 mEq/mL, 50 mL vial, 25 count, NDC 00409-3924-51
Reason for the Shortage
-
- Exela has potassium acetate injection available.
- Pfizer has potassium acetate injection on shortage due to manufacturing delays.
Available Products
-
- Potassium acetate injection, Exela Pharma Sciences, 2 mEq/mL, 100 mL vial, 25 count, NDC 51754-2004-04
- Potassium acetate injection, Exela Pharma Sciences, 2 mEq/mL, 20 mL vial, 25 count, NDC 51754-2001-04
Estimated Resupply Dates
-
- Pfizer has potassium acetate 2 mEq/mL 20 mL vials on back order and the company estimates a release date of May 2024. The 50 mL vials are available only for emergency use via direct orders.
Updated
Updated April 10, 2024 by Michelle Wheeler, PharmD, Drug Information Specialist. Created September 1, 2021 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2024, Drug Information Service, University of Utah, Salt Lake City, UT.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.